Reese Jones, MD

Professor

Publications

  1. Herbst ED, Harris DS, Everhart ET, Mendelson J, Jacob P, Jones RT. Cocaethylene formation following ethanol and cocaine administration by different routes. Volume 19 of Issue 2. Experimental and clinical psychopharmacology 2011. PMID: 21463066


  2. Harris DS, Everhart T, Jacob P, Lin E, Mendelson JE, Jones RT. A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. Volume 9. BMC clinical pharmacology 2009. PMID: 19646280


  3. Mendelson JE, McGlothlin D, Harris DS, Foster E, Everhart T, Jacob P, Jones RT. The clinical pharmacology of intranasal l-methamphetamine. Volume 8. BMC clinical pharmacology 2008. PMID: 18644153


  4. Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT. Human pharmacology of the methamphetamine stereoisomers. Volume 80 of Issue 4. Clinical pharmacology and therapeutics 2006. PMID: 17015058


  5. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Repeated psychological stress testing in stimulant-dependent patients. Volume 29 of Issue 5. Progress in neuro-psychopharmacology & biological psychiatry 2005. PMID: 15913869


  6. Uemura N, Nath RP, Harkey MR, Henderson GL, Mendelson J, Jones RT. Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. Volume 28 of Issue 4. Journal of analytical toxicology 2004. PMID: 15189676


  7. Harris DS, Mendelson JE, Lin ET, Upton RA, Jones RT. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Volume 43 of Issue 5. Clinical pharmacokinetics 2004. PMID: 15080765


  8. Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Volume 72 of Issue 2. Drug and alcohol dependence 2003. PMID: 14636972


  9. Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT. The bioavailability of intranasal and smoked methamphetamine. Volume 74 of Issue 5. Clinical pharmacology and therapeutics 2003. PMID: 14586388


  10. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Volume 28 of Issue 9. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003. PMID: 12813474


  11. Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Volume 70 of Issue 2 Suppl. Drug and alcohol dependence 2003. PMID: 12738348


  12. Jones RT. Cardiovascular system effects of marijuana. Journal of clinical pharmacology 2002. PMID: 12412837


  13. Lester L, Uemura N, Ademola J, Harkey MR, Nath RP, Kim SJ, Jerschow E, Henderson GL, Mendelson J, Jones RT. Disposition of cocaine in skin, interstitial fluid, sebum, and stratum corneum. Volume 26 of Issue 8. Journal of analytical toxicology 2002. PMID: 12501911


  14. Jacob P, Wilson M, Yu L, Mendelson J, Jones RT. Determination of 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry. Analytical chemistry 2002. PMID: 12403583


  15. Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Volume 162 of Issue 4. Psychopharmacology 2002. PMID: 12172693


  16. Delucchi KL, Batki SL, Moon J, Jacob P, Jones RT. Urine toxicology samples in cocaine treatment trials: how many need to be tested? Volume 21 of Issue 2. Journal of addictive diseases 2002. PMID: 11916369


  17. Hall SM, Tunstall CD, Ginsberg D, Benowitz NL, Jones RT. Nicotine gum and behavioral treatment: a placebo controlled trial. Volume 55 of Issue 4. Journal of consulting and clinical psychology 1987. PMID: 3624619